







© MOLNLYCKE HEALTH CARE VENDA DE PRODUTOS MÉDICOS CNPJ: 12.600.168/0002-06
1. Kramer A, Dissemond J. Kim S et al. Consensus on wound antisepsis: update 2018. Skin Pharmacol Physiol, 2018;31:28-58, https://doi.org/10.1159/000481545.
2. Teste de suspensão in vitro.
3. Del Rosso et. al., Status Report on Topical Hypochlorous Acid:
Clinical Relevance of Specific Formulations, Potential Modes of Action, and Study Outcomes, J Clin Aesthet Dermatol. 2018;11(11):36-39.
4. Consensus on Wound Antisepsis: Update 2018, Skin Pharmacol Physiol 2018:31:28-58, DOI: 10.1159/000481545.
5.Severing et al, Safety and efficacy profiles of different commercial sodium hypochlorite/hypochlorous acid solutions, J Antimicrob Chemother, 2018.
6. Method Ph.Eur. 2.2.35, test conducted by BIOSERV Analytik- und Medizinprodukte GmbH, Rostock, Germany.
7. Granudacyn Wound Irrigation Solution and Wound Gel. J Wound Care. 2020 Oct 1;29(Sup10a):S9. doi: 10.12968/jowc.2020.29.Sup10a.S9. PMID: 33016842.
8. Sakarya S, Gunay N, Karakulak M, Ozturk B, Ertugrul B. Hypochlorous acid: an ideal wound care
agent with powerful microbicidal, antibiofilm, and wound healing potency. Wounds. 2014;26(12):342-350.